State Disclosures

The following information is being provided to Colorado prescribers pursuant to Colorado law HB 19-1131.

The price information provided represents the Wholesale Acquisition Costs ("WAC") as made available to the public by a third-party publisher. WAC does not reflect discounts, rebates and other reductions in price. The actual price paid by patients may differ and is dependent upon the individual patient’s insurance.

Adalimumab-aacf-Colorado-form 10-2024

Filename: Adalimumab-aacf-Colorado-form 11-2024.pdf
Size: 84 KB
Format: pdf

Download Adalimumab aacf State Disclosure Colorado

Diprivan Disclosure Form

Information for Colorado Prescribers of Diprivan

Filename: Diprivan-Colorado-form 11-2024.pdf
Size: 88 KB
Format: pdf

Download Diprivan State Disclosure Colorado

IDACIO-Colorado-form 10-2024

Filename: IDACIO-Colorado-form 11-2024.pdf
Size: 85 KB
Format: pdf

Download IDACIO State Disclosure Colorado

Intralipid-Colorado-form 10-2024

Filename: Intralipid-Colorado-form 11-2024.pdf
Size: 85 KB
Format: pdf

Download Intralipid State Disclosure Colorado

KABIVEN-Colorado-form 10-2024

Filename: KABIVEN-Colorado-form 11-2024.pdf
Size: 85 KB
Format: pdf

Download KABIVEN State Disclosure Colorado

Omegaven-Colorado-form 10-2024

Filename: Omegaven-Colorado-form 11-2024.pdf
Size: 80 KB
Format: pdf

Download Omegaven State Disclosure Colorado

Smoflipid-Colorado-form 10-2024

Filename: Smoflipid-Colorado-form 11-2024.pdf
Size: 83 KB
Format: pdf

Download Smoflipid State Disclosure Colorado

Stimufend-Colorado-form 10-2024

Filename: Stimufend-Colorado-form 11-2024.pdf
Size: 96 KB
Format: pdf

Download Stimufend State Disclosure Colorado

Tyenne-Colorado-form 10-2024

Filename: Tyenne-Colorado-form 11-2024.pdf
Size: 84 KB
Format: pdf

Download Tyenne State Disclosure Colorado

Information for Connecticut Prescribers of Prescription Drugs

Connecticut law HB 6669 requires the disclosure of the list price of a legend drug when a pharmaceutical representative provides information concerning such legend drug to prescribing practitioners or pharmacists, based on the dose and quantity of such legend drug as described in the medication package insert.